A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This randomised, double-blind, placebo-controlled study will evaluate the efficacy and safety of ADC3680 administered once daily as an add-on therapy to inhaled corticosteroids and when co-administered with montelukast in patients with inadequately-controlled asthma. Patients will be randomised to 3 Arms to receive ADC3680, placebo or montelukast.
Epistemonikos ID: 9b0864618955a103a7da6cdfb3eb111a6ce666c1
First added on: May 11, 2024